A. H. Strickland

2.2k total citations
66 papers, 1.1k citations indexed

About

A. H. Strickland is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Plant Science. According to data from OpenAlex, A. H. Strickland has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 13 papers in Plant Science. Recurrent topics in A. H. Strickland's work include Colorectal Cancer Treatments and Studies (24 papers), Gastric Cancer Management and Outcomes (14 papers) and Lung Cancer Treatments and Mutations (7 papers). A. H. Strickland is often cited by papers focused on Colorectal Cancer Treatments and Studies (24 papers), Gastric Cancer Management and Outcomes (14 papers) and Lung Cancer Treatments and Mutations (7 papers). A. H. Strickland collaborates with scholars based in United Kingdom, Australia and United States. A. H. Strickland's co-authors include Christos S. Karapetis, Desmond Yip, Timothy Price, Niall C. Tebbutt, Marc Peeters, Val Gebski, Michelle M. Cummins, Vinod Ganju, Eric Van Cutsem and T. Sourjina and has published in prestigious journals such as Journal of Clinical Oncology, Gut and Annual Review of Entomology.

In The Last Decade

A. H. Strickland

60 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. H. Strickland United Kingdom	17	422	366	204	156	152	66	1.1k
S. Caruso Italy	19	253 0.6×	358 1.0×	458 2.2×	261 1.7×	108 0.7×	61	1.2k
Charlotte Baey France	11	258 0.6×	290 0.8×	267 1.3×	38 0.2×	87 0.6×	25	869
I. Barneto Spain	13	759 1.8×	622 1.7×	118 0.6×	26 0.2×	331 2.2×	39	1.2k
Francesco Leonardi Italy	16	359 0.9×	341 0.9×	321 1.6×	75 0.5×	119 0.8×	60	909
Jean‐Marie Saint‐Remy Belgium	25	112 0.3×	116 0.3×	78 0.4×	13 0.1×	360 2.4×	71	2.1k
Raja Marrakchi Tunisia	20	180 0.4×	70 0.2×	205 1.0×	27 0.2×	423 2.8×	74	1.0k
Hajime Yoshisue Japan	14	101 0.2×	232 0.6×	78 0.4×	93 0.6×	239 1.6×	36	770
Zarina S. Lalmahomed Netherlands	15	658 1.6×	195 0.5×	276 1.4×	7 0.0×	165 1.1×	24	1.0k
Robert J. Jacobson United States	27	357 0.8×	140 0.4×	64 0.3×	565 3.6×	594 3.9×	65	3.2k
James A. Richmond United Kingdom	15	92 0.2×	78 0.2×	364 1.8×	41 0.3×	221 1.5×	38	1.0k

Countries citing papers authored by A. H. Strickland

Since Specialization

Citations

This map shows the geographic impact of A. H. Strickland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. H. Strickland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. H. Strickland more than expected).

Fields of papers citing papers by A. H. Strickland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. H. Strickland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. H. Strickland. The network helps show where A. H. Strickland may publish in the future.

Co-authorship network of co-authors of A. H. Strickland

This figure shows the co-authorship network connecting the top 25 collaborators of A. H. Strickland. A scholar is included among the top collaborators of A. H. Strickland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. H. Strickland. A. H. Strickland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leong, Trevor, B. Mark Smithers, Karin Haustermans, et al.. (2024). LBA58 A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTG. Annals of Oncology. 35. S1249–S1249. 1 indexed citations

Strickland, A. H. & Bonnie L. Brown. (2024). Population genomics of eastern oysters, Crassostrea virginica, in a well-mixed estuarine system: advancement and implications for restoration strategies. BMC Genomics. 25(1). 1171–1171. 2 indexed citations

Strickland, A. H., et al.. (2024). Diet of the blue crab (Callinectes sapidus) during range expansion in Great Bay Estuary, New Hampshire. BMC Genomics. 25(1). 1238–1238.

Day, Daphne, Val Gebski, John Simes, et al.. (2023). 586P Minimal residual disease (MRD) detection using a tumour naïve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial. Annals of Oncology. 34. S426–S427. 1 indexed citations

Diakos, Connie I., Val Gebski, Sidney Kam‐Hung Yip, et al.. (2016). Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies. Annals of Oncology. 27. vi196–vi196. 2 indexed citations

Hazel, Guy A. Van, Volker Heinemann, Navesh Sharma, et al.. (2015). O-019 SIRFLOX: Randomized trial comparing first-line mFOLFOX6 ± bevacizumab versus mFOLFOX6 + selective internal radiation therapy (SIRT) ± bevacizumab in patients with metastatic colorectal cancer (mCRC) – analysis by presence or absence of extra-hepatic metastases and bevacizumab treatment. Annals of Oncology. 26. iv115–iv115.

Peeters, Marc, Kelly S. Oliner, Timothy Price, et al.. (2014). KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analysis. Annals of Oncology. 25. ii5–ii5. 2 indexed citations

Chalmers, John, et al.. (2013). PWE-038 Patient Controlled Propofol – do we Need an Anaesthetist?. Gut. 62(Suppl 1). A145.3–A146. 1 indexed citations

Murphy, Felicity, Diana Zannino, Kate Wilson, et al.. (2011). Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. Annals of Oncology. 22(8). 1834–1838. 38 indexed citations

10.

Tebbutt, Niall C., Michelle M. Cummins, T. Sourjina, et al.. (2010). Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial. British Journal of Cancer. 102(3). 475–481. 92 indexed citations

11.

Peeters, Marc, Andrés Cervantes, A. H. Strickland, et al.. (2010). Randomized phase III study of panitumumab (pmab) with FOLFIRI versus FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis by tumor epidermal growth factor receptor (EGFR) staining.. Journal of Clinical Oncology. 28(15_suppl). 3565–3565. 11 indexed citations

12.

Michael, Michael, Timothy Price, Samuel Y. Ngan, et al.. (2008). A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer. British Journal of Cancer. 100(1). 37–43. 4 indexed citations

13.

Harper, Peter, Christos S. Karapetis, Desmond Yip, et al.. (2001). Epirubicin, Cisplatin, and Prolonged or Brief Infusional 5-Fluorouracil in the Treatment of Carcinoma of Unknown Primary Site. Medical Oncology. 18(1). 23–32. 2 indexed citations

14.

Strickland, A. H., et al.. (2001). Evaluating On- and Off-the-Job Approaches to Learning and Assessment in Apprenticeships and Traineeships. Australian Apprenticeships.. 3 indexed citations

15.

Halford, Sarah, Desmond Yip, Christos S. Karapetis, et al.. (2001). A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma. Annals of Oncology. 12(10). 1399–1402. 51 indexed citations

16.

Yip, Desmond, et al.. (2000). Immunomodulation therapy in colorectal carcinoma. Cancer Treatment Reviews. 26(3). 169–190. 16 indexed citations

17.

Strickland, A. H., et al.. (1998). Increased survival in patients diagnosed with Hodgkin's disease in Tasmania, 1972–1992. Australian and New Zealand Journal of Medicine. 28(5). 609–614.

18.

Strickland, A. H.. (1966). Some Costs of Insect Damage and Crop Protection. 12(1-2). 57–72. 3 indexed citations

19.

Strickland, A. H.. (1966). Some Estimates of Insecticide and Fungicide Usage in Agriculture and Horticulture in England and Wales, 1960-64. Journal of Applied Ecology. 3. 3–3. 13 indexed citations

20.

Strickland, A. H.. (1960). Pest and Disease Losses in Agriculture. The New Scientist. 8(199). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact